A new method for sequencing the chemical groups attached to the surface of DNA is paving the way for better detection of cancer and other diseases in the blood. These chemical groups mark one of the four DNA 'letters' in the genome, and it is differences in these marks along DNA that control which genes are expressed or silenced.